The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

The rapid advances in deep learning-based computational pathology and radiology have demonstrated the promise of using whole slide images (WSIs) and radiology images for survival prediction in cancer ...

A complex endocrine disorder with genetic roots, affecting women's health and fertility, requiring early intervention.

Survival outcome prediction is a challenging weakly-supervised and ordinal regression task in computational pathology that involves modeling complex interactions within the tumor microenvironment in ...

There's a long way to go when it comes to sex and gender equity in medicine, but engineers at The University of New Mexico hope to close the gap with ...

Tennis legend Chris Evert, a two-time ovarian cancer survivor, is advocating for awareness and genetic screening after her ...

Doctors at Jehangir Hospital in Pune removed an 18-kg ovarian tumor from a 68-year-old woman, improving her health and quality of life.

An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with platinum-resistant ovarian cancer.

Polycystic ovary syndrome (PCOS) is a highly prevalent endocrinopathy among women of reproductive age, characterized by reproductive, metabolic and psychological features, which affects about 5%-10% ...

Models of ovarian carcinogenesis have separated epithelial tumors into major pathways with distinct cells of origin, carcinogenic pathways, and histology with different clinical behavior. 8, 10 An ...